Clinical Trial Update: Effect of Add-on L-Arginine Therapy on Heart Failure Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating add-on L-Arginine therapy in heart failure patients. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: German University in Cairo | Conditions: Heart Failure | Phase 2 | Status: NOT_YET_RECRUITING